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Abstract
Background: In the field of drug and alcohol abuse, health-related quality of life (HRQoL) has been used as an
important clinical and research outcome. The aim of this study was to establish score linkages (concordance)
among three HRQoL assessment tools: WHOQOL-BREF, DUQOL and HRQOLDA scores, applying a Rasch-based
common person equating procedure.
Methods: One hundred and twenty one adults were recruited from inpatient and outpatient treatment facilities in
Sydney West Area Health Service. WHOQOL-BREF, DUQOL and HRQOLDA tests were administered. Item parameters
were calculated applying Rating Scale Model, a Rasch model.
Results: Fit statistics suggest acceptable goodness-of-fit to the RSM for three instruments. Correlations between
HRQOLDA and WHOQOL-BREF and between HRQOLDA and DUQOL scores were 0.719 and 0.613, and the RiU
index was 30.4 % and 20.9 %, respectively. All three tests performed adequately for differentiating between
individuals whose scores are located at different points along the continuum of the HRQoL construct.
Conclusion: The results demonstrated a higher concordance between the HRQoLDA and WHOQOL-BREF than
between the HRQoLDA and the DUQOL. However, it cannot be established unequivocally that the scores of these
tools are concordant. In this study, the utility of the application of the Rasch model to provide an empirical benchmark
for the selection of measurement tools to be used in the context of health care and research is demonstrated.
Keywords: Health-related quality of life, Health-related quality of life test, Substance users, Score linkage, Concordance,
Rasch models
Background
In the field of drug and alcohol abuse, HRQoL has been
used as an important clinical and research outcome.
HRQoL started to be used as a complementary outcome
measure to “hard” indicators, such as criminal behav-
iours, unemployment, and illicit drug use [1]. The con-
cept of HRQoL is also used in drug abuse research and
clinical practice, including the assessment of the impact
of therapeutic interventions on patient’s lives [2, 3].
In the field of substance use, HRQoL has been mea-
sured mainly via generic tests. These tests evaluate rep-
resentative behaviours from daily activities and most
frequent symptoms in normal persons. The World
Health Organization Quality of Life (WHOQOL-BREF)
is a generic questionnaire, which has been used widely
as assessment tool in epidemiological research. The
WHOQOL-BREF has been translated to various lan-
guages and tested internationally [4, 5].
In recent years, specific tests have been developed to
assess quality of life in the context of substance use, in-
cluding the Injection Drug Users Quality of Life Scale
(IDUQOL) [6, 7]; the Quality of Life Scale for Drug
Addicts (QOL-DA) [8]; and the Health-Related Quality
of Life for Drug Abusers test (HRQOLDA) [9, 10]. By
contrast, the Drug User Quality of Life Scale is a specific
instrument, which was originally developed to assess the
quality of life of intravenous substance users [6, 7]; a later
version has been adapted for substance users irrespective
of their methods of self-administration (DUQOL) [11].
This instrument was conceptualized using the World
Health Organization’s definition of quality of life. There
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are versions of the DUQOL available both in English
[6, 7] and Spanish [11], and both present sound psycho-
metric properties of reliability and validity – statistical ana-
lyses revealed an ICC score of 0.71 [6], a Cronbach's alpha
coefficient of 0.86 and a test-retest reliability of 0.79 [11],
with favorable evidence of convergent validity [6], content
validity evidence [7], and criterion-related validity [11]).
The HRQoLDA [10] or TECVASP test as originally
conceived in the Spanish language [9], as a quality of life
instrument designed to specifically assess the quality of
life of substance users. This specific instrument was de-
veloped to assist clinicians and researchers to determine
to what extent and intensity substance use and drug ad-
diction affect Quality of Life (QoL). The HRQoLDA is a
brief assessment tool, which measures aspects related to
the physical, psychological and social consequences of
substance use. The HRQoLDA is a reliable instrument
for evaluating quality of life of substance users, which has
demonstrated a significant Cronbach's alpha coefficient of
0.905, with sound evidence of convergent validity [10].
Numerous methods have been developed over the
years for correlating measurement tests and scales. The
term linking refers to the general class of transforma-
tions between the scores from one test to another [12].
Three main methodologies have been proposed to select
the best applicable score linkage to a given scenario,
which are equating, scale aligning, and prediction [13].
The use of any of these approaches depends on con-
struct similarity between tests, as well as difficulty, reli-
ability, and constancy of the linkage relationship across
populations [14]. Equating is the strongest form of link-
ing between test scores, whereas prediction is considered
the weakest. Concordance, a scale aligning subcategory,
is used in tests that measure similar constructs accord-
ing to different blueprints or test content specifications
[15]. Concordance is a form of linking to establish score
comparability from different tests that measure ideally
similar, but not necessarily equivalent constructs, to be
used approximately in the same way and given similar
interpretations [16]. Concordance represents scaling of
tests that were not created with the idea that their scores
would be used interchangeably [15].
The WHOQOL-BREF, DUQOL and HRQoLDA are
different tests that measure HRQoL construct, but their
operational definitions are distinct. However, the three
tests are currently used to assess HRQoL in the field of
addiction. In this study, the authors present the results
of analyses to assess the concordance of WHOQOL-
BREF, DUQOL and HRQoLDA scores via a Rasch-based
common person equating procedure. Common person
equating procedure is conventionally used to evaluate
different tests administered to a common group of re-
search participants. The specific aim of this study was to
establish score linkages (concordance), using a Rasch-
based common person equating procedure, between the
DUQOL and HRQoLDA and between WHOQOL-BREF
and HRQoLDA.
Methods
Sample
This study evaluated 121 adults recruited from inpatient
and outpatient treatment facilities across the Sydney
West Area Health Service (SWAHS) catchment area in
western Sydney, Australia. Research sites included Black-
town Hospital, Cumberland Hospital, Nepean Hospital,
and the Mount Druitt Centre for Addiction Medicine,
all of which are higher education training facilities
within Sydney West Area Health Service (SWAHS).
Potential participants presenting for treatment were
randomly invited to respond to the questionnaires. The
inclusion criteria consisted of fulfilment of the DSM-IV
criteria for substance abuse disorders (substance de-
pendence and abuse disorders) and the ability to under-
stand the aim of the study, as well as the content of the
questions in both questionnaires, which entailed a satis-
factory command of English. Exclusion criteria com-
prised of presentations exclusively due to alcohol abuse
and/or involuntary admission for inpatient treatment.
This study was granted approval by the SWAHS
Human Research Ethics Committee. Prospective partici-
pants were provided with a written protocol pertaining
to the study and a verbal explanation about the purpose
of the study. They were also informed that participation
was voluntary, confidential and anonymous. Volunteers
were also informed that they could withdraw from this
study at any time without any repercussion to their
treatments. Research participants were then asked to
sign an informed consent form prior to their inclusion
in the study.
Instruments
HRQOLDA
The HRQoLDA Test is a quality-of-life assessment tool
specific for drug abuse. It assesses the physical and psy-
chosocial aspects of life through 20 five-choice items in
a Likert-type scale, with choices being designated 1 to 5
points. The sum of the 20 scores represents quality of
life, such that the higher the score, the better the quality
of life.
DUQOL Scale: This scale is a specific measure of indi-
vidual quality of life in drug users. It consists of 22 items
relevant to the physical, social, psychological, occupa-
tional, and geographical reality of life, rated on a seven-
point Likert-type scale ranging from 1 (very dissatisfied)
to 7 (very satisfied). Higher test scores indicate better
overall QOL.
WHOQOL-BREF Questionnaire. This generic question-
naire comprises 26 items, which measure the following
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broad domains: physical health, psychological health, social
relationships, and environment. It consists of 24 questions
chosen from the original WHOQOL-100 question-
naire, and 2 questions about satisfaction with Overall
Quality of Life and General Health. The items have a
five-point Likert-type scale ranging from 1 (lowest
agreement) to 5 (highest agreement). Higher score in-
dicates better QOL.
Procedure
Five data collectors underwent a period of training and
supervision by the principal investigator prior to admin-
istering questionnaires independently. The data collec-
tors met regularly to address any queries and ensure
each were following the same procedure.
The study participants completed the tests under min-
imal guidance from the trained examiners, who followed
standardized instructional procedures. Interviews took
place in a suitable room at the research sites mentioned
above. Occasionally, specific questions not considered in
the initial instruction procedure were answered on a
one-to-one basis. Particular care was taken with non-
native English speaking participants in order to ensure a
satisfactory understanding.
Analysis
The Rating Scale Model (RSM), a Rasch model for poly-
tomous items, was used in the psychometric analysis
[17]. The RSM is an extension to Rasch’s logistic model
and is suitable for use when items are scored polyto-
mously. In this study, the probability of response to an
item is a logistic function determined by person HRQoL
and the severity of item ‘δ’ at category ‘x’. This model
transforms person and item raw scores to interval mea-
sures, which can be located on the same metric. Inter-
pretations of the person’s HRQoL and item severity were
carried out by transforming data to the “logit” scale.
When logit measures are compared between tests
(tests of the same construct with different items), their
probabilistic meaning is maintained but their substantive
meanings may differ. Logit measures underlying differ-
ent tests must be equated before the measures can be
meaningfully compared [18].
Rasch analysis results are interpretable when data fit
the model. The residual fit statistics used were the
INFIT and OUTFIT indexes for each item and person.
The INFIT index is sensitive to unexpected behavior
affecting responses to items near the person's measure
level (inliers) while the OUTFIT index is sensitive to un-
expected behavior by persons on items far from the
person's measure level (outliers) [18]. Both statistics can
be reported by mean square residual (MnSq) and z-
standardized mean square residual (Zstd). Acceptable
values of MnSq statistics are between 0.5 and 1.5, where
1 is ideal [18]. Values larger than 1.5 indicate unmodeled
noise or other source of variance in the data. Values less
than 1.0 indicate overly predictable figures (overfit). In
Zstd, 0 indicates that the model adequately predicts the
observed data, and the range of −2 to +2 indicates an ac-
ceptable fit [18]. All analysis was conducted with WIN-
STEPS software version 3.64.2 [19].
Considering that Rasch Models assumes unidimen-
sionality, a parallel analysis was conducted to test di-
mensionality of HRQoLDA, the WHOQOL-BREF and
the DUQOL. In parallel analysis, the mean eigenvalues
and 95th percentile for the eigenvalues from random
data were utilized as a baseline for determining dimen-
sionality. All Factors with values greater than the base-
line parameters (eigenvalues based on random data)
were retained. The computer programs for parallel ana-
lysis used was developed by Patil, Singh, Mishra, &
Donavan [20]. The results are compatible with the unidi-
mensionality of the measures (see Fig. 1).
In order to check concordance between scores, a
Reduction in Uncertainty (RiU) index was utilized [14].
This index reports information about statistical certainty
of a dependent variable from a predictor variable. Accord-
ing to Dorans and Walker, RiU = 1-SQR (1-r2), where r is
the correlation coefficient between both test scores [15].
When r = 0, there is a 0 % reduction; when r = 1, there is
100 % reduction. It is reasonable to expect at least 50 % of
uncertainty reduction in one score resulted from the other
score [15].
Results
Fit between Data and Model
Table 1 shows the fit statistics of the HRQOLDA,
WHOQOL-BREF and DUQOL instruments. Only Item
19 for HRQOLDA test, Item 2 for DUQOL scale and
Item 17 for WHOQOL-BREF questionnaire have infit
(MnSq and Zstd) and outfit (MnSq and Zstd) values
above the acceptable range. Fits statistics suggest accept-
able goodness-of-fit to the RSM for three instruments.
Concordance among the DUQOL, HRQOLDA and
WHOQOL-BREF Scores
Common-person’s equating of two instruments involves
an assessment of the invariance of person’s estimates of
a single-sample. The RSM person’s estimates (logit scale)
for each person in both tests are displayed in a scatter-
plot; the plots should fall on a single line with allowance
made for the modeled standard error pairs for each per-
son’s estimates [21]. Figure 2 shows the scatterplot of
RSM person’s estimates of the HRQoLDA and the
WHOQOL-BREF against each other, the scatterplot of
RSM person’s estimates of the HRQoLDA and the
DUQOL in similar comparison, and the scatterplot of
RSM person’s estimates of the WHOQOL-BREF and the
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DUQOL against each other as well. The 95 % confidence
band provides a means to evaluate the extent to which the
two tests are measuring the same construct within a rea-
sonable degree of measurement error.
Before displaying the scatterplot, following the recom-
mended steps for common subject equating [21], the
mean of the ability estimates for each person in each
instrument was achieved. Subsequently, the differences
between the means were computed - HRQoLDA was
compared by using as the point of reference 0.00 logits:
the HRQOLDA mean (0.29 logits), and WHOQOL-BREF
mean (0.20 logits) were contrasted with the HRQoLDA
mean and DUQOL mean (0.14 logits). The person ability
estimates by the mean difference (add the difference to
each estimate) were recalculated: HRQoLDA mean (0.00
logits), WHOQOL-BREF mean (0.04 logits), and DUQOL
mean (0.28 logits).
In Fig. 2, about 80 % of all plots are located inside the
confidence interval, whereas in Figs. 2, about 60 % of all
plots are located inside the confidence interval. The
degree of concordance of health-related quality of life
measures among the instruments varies. Under ideal cir-
cumstances of perfect concordance, the empirical regres-
sion line should have a slope of 1 and an intercept of 0.
The slope of the empirical regression line is 0.707 and the
intercept 0.039, when HRQoLDA and WHOQOL-BREF
Fig. 1 Parallel analysis graphics of HRQOLDA, WHOQOL-BREF and DUQOL
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Table 1 Item measures and fit statistics for the items
WHOQOL-BREF INFIT OUTFIT DUQOL INFIT OUTFIT HRQoLDA INFIT OUTFIT
ME SE MNSQ ZEMP MNSQ ZEMP R ME SE MNSQ ZEMP MNSQ ZEMP R ME SE MNSQ ZEMP MNSQ ZEMP R
1 .11 .09 .70 −1.0 .68 −1.1 .73 1 .03 .05 1.11 .4 1.16 .6 .49 1 .42 .08 1.10 .3 1.04 .1 .63
2 .31 .09 .69 −1.0 .75 −.8 .65 2 .30 .05 1.60 2.1 1.76 2.5 .27 2 .81 .09 1.05 .2 1.07 .2 .63
3 −.41 .09 1.68 1.6 1.75 1.8 .38 3 −.27 .06 1.00 .0 1.03 .1 .42 3 −.50 .09 .76 −.7 .70 −.7 .65
4 .31 .09 1.40 1.1 1.47 1.3 .35 4 .11 .05 1.12 .5 1.18 .7 .40 4 .90 .09 .82 −.5 .96 −.1 .64
5 −.06 .09 .69 −1.0 .66 −1.2 .70 5 −.06 .05 1.13 .5 1.11 .4 .51 5 .66 .08 .56 −1.4 .54 −1.4 .81
6 .07 .09 .89 −.3 .88 −.4 .63 6 .20 .05 .58 −2.1 .60 −1.9 .74 6 .41 .08 .68 −1.0 .62 −1.1 .76
7 .21 .09 .68 −1.1 .69 −1.0 .60 7 .07 .05 .90 −.4 .92 −.3 .54 7 .09 .08 .85 −.4 .80 −.5 .65
8 −.27 .09 .83 −.5 .87 −.4 .64 8 −.22 .05 1.30 1.0 1.39 1.2 .38 8 .48 .08 .76 −.7 .72 −.8 .72
9 −.18 .09 1.09 .3 1.08 .3 .49 9 .16 .05 .81 −.8 1.16 .6 .57 9 −1.08 .11 1.22 .4 1.30 .5 .43
10 .03 .09 .66 −1.1 .89 −.3 .64 10 −.28 .06 1.01 .1 1.03 .1 .47 10 .45 .08 .62 −1.2 .60 −1.2 .77
11 −.27 .09 1.11 .3 1.12 .4 .55 11 −.18 .05 1.32 1.1 1.23 .8 .49 11 −.84 .10 .89 −.2 .84 −.3 .55
12 .37 .09 1.31 .9 1.32 .9 .47 12 −.18 .05 .70 −1.2 .68 −1.2 .60 12 −.11 .08 1.69 1.6 1.51 1.1 .51
13 −.42 .09 .83 −.5 .82 −.5 .61 13 .16 .05 .88 −.5 .87 −.5 .58 13 −.13 .08 1.60 1.4 1.41 .9 .53
14 .14 .09 .94 −.2 .99 .0 .56 14 .36 .05 1.02 .1 1.01 .1 .50 14 −.33 .08 1.01 .0 1.09 .2 .62
15 -.51 .09 1.13 .4 1.11 .3 .57 15 -.09 .05 1.12 .5 1.09 .3 .46 15 .07 .08 .61 −1.2 .60 −1.2 .73
16 .45 .09 1.04 1 1.06 .2 .54 16 .12 .05 1.09 .4 1.12 .5 .43 16 −.06 .08 .56 −1.5 .53 −1.4 .78
17 .02 .09 .42 −2.2 .44 −2.2 .75 17 −.16 .05 .71 −1.2 .79 −.7 .45 17 −.19 .08 1.36 .9 1.53 1.1 .31
18 .36 .09 .75 −.8 .73 −.9 .68 18 .17 .05 1.18 .7 1.17 .7 .42 18 .10 .08 1.04 .1 1.12 .3 .56
19 .24 .09 .55 −1.6 .55 −1.6 .77 19 −.12 .05 1.06 .2 1.05 .2 .45 19 .06 .08 1.94 2.1 2.09 2.2 .32
20 .24 .09 1.04 .1 1.03 .1 .62 20 −.06 .05 1.14 .5 1.15 .6 .42 20 −1.21 .12 1.46 .7 2.25 1.4 .13
21 .31 .09 1.47 1.3 1.54 1.4 .40 21 .02 .05 .70 −1.3 .68 −1.4 .63
22 −.01 .09 1.23 .7 1.24 .7 .46 22 −.06 .05 .59 −1.9 .57 −1.9 .67
23 −.38 .09 1.37 1.0 1.34 .9 .54
24 −.69 .10 1.24 .6 1.24 .6 .37
25 −.28 .09 1.67 1.7 1.63 1.6 .43
26 .30 .09 .77 −.8 .75 −.8 .68
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Table 1 Item measures and fit statistics for the items (Continued)
ITEM summary ITEM summary ITEM summary
MEAN .00 .09 1.01 −.1 1.02 .0 MEAN .00 .05 1.00 −.1 1.04 .1 MEAN .00 .09 1.03 −.1 1.07 .0
S.D. .31 .00 .33 1.0 .34 1.0 S.D. .18 .00 .25 1.0 .26 1.0 S.D. .57 .01 .39 1.0 .48 1.0
PERSONS summary PERSONS summary PERSONS summary
MEAN .02 .20 1.02 −.1 1.02 −.1 MEAN .14 .13 1.02 −.1 1.04 .0 MEAN .29 .22 1.03 .0 1.07 1
S.D. .72 .04 .48 1.0 .48 1.0 S.D. .37 .04 .42 1.0 .43 1.0 S.D. .73 .06 .49 1.0 .59 1.0
ME: Items Measures; SE: Standard Errors; INFIT: information-weighted fit statistic; OUTFIT: is an outlier-sensitive fit statistic; MNSQ: Mean Square Residual; ZEMP: z-Standardized Mean
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Fig. 2 Common person equating: HRQOLDA test and WHOQOL-BREF Questionnaire (a), HRQOLDA test and DUQOL scale (b), and WHOQOL-BREF
Questionnaire and DUQOL scale (c). Dots represent persons. The black line represents the empirical regression line. The dotted lines represent the
estimates’ 95 % CI
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are compared (R2 = 0.517). The slope of the empirical
regression line is 0.309 and the intercept 0.279, when
HRQoLDA and DUQOL are compared (R2 = 0.376).
Correlations between HRQoLDA and WHOQOL-BREF
and between HRQoLDA and DUQOL scores were 0.719
and 0.613, respectively. The RiU index between HRQoLDA
and WHOQOL-BREF was 30.4 % and between HRQoLDA
and DUQOL was 20.9 %.
Severity item estimates
The analyses of the items yielded a severity item range
(Table 1) for HRQoLDA test of −1.21 to 0.90 logits (x̄ = 0;
SD = 0.57); for WHOQOL-BREF questionnaire the re-
spective values were −0.69 to 0.46 logits (x̄ = 0; SD = 0.31),
and for DUQOL scale the values were - 0.28 to 0.36 logits
(x̄ = 0; SD = 0.18).
The map of persons and items (Fig. 3) shows the com-
bined position of the HRQoLDA, the DUQOL and the
WHOQOL-BREF severity of items on the HRQoL con-
tinuum (right side). This map shows the item hierarchy
that measured by the instruments. The HRQoL con-
tinuum is shown on the left of the plot, while on the
right of plot the items appear in an order according to
their severity values on the HRQoL continuum. It can
be seen in Fig. 3 that the range of severity of items is
greater in the HRQoLDA in comparison with the
WHOQOL-BREF and the DUQOL. The DUQOL shows
the lowest range of severity of items. The measurements
of the persons by test are displayed on the left side are.
The map of persons and items is useful for comparing
the range and position of the items and can be also uti-
lized to measure person’s distributions. In order to
develop a proper measure for all persons, the items must
cover all the areas on the HRQoL continuum.
Reliability, separation and standard errors of
measurement
In general, with Rasch models, an analysis is carried out
to compute a separation index for and for items, instead
of reliability coefficients. Person Separation Index (PSI)
is used to classify people; it represents the number of
statistically different performance strata that the instru-
ment can detect in the sample. Low person’s separation
(less than 2) indicates that the instrument could be not
sensitive enough to classify between people with high
and low ability [18]. The HRQoLDA, the WHOQOL-
BREF and the DUQOL person separation index were of
3.02, 3.09 and 2.58, respectively.
Item Separation Index (ISI) is used to demonstrate
item hierarchy. The hierarchy of item severities is particu-
larly important given that the planned items severity in
the test content specifications can be compared with the
order estimated from the data [18]. Low item separation
(less than 3) implies that the person’s sample is not large
enough to confirm the items hierarchy of the instrument
(and that the test has no item with high, medium or low
severity) [18]. The values of the HRQoLDA, WHOQOL-
BREF and DUQOL item separation indexes were respect-
ively 6.41, 3.30 and 3.28.
The Rasch reliability (of persons) is comparable to
the traditional reliability of the test. The HRQoLDA,
WHOQOL-BREF and DUQOL reliability coefficients
were 0.90, 0.92 and 0.87, respectively. In Rasch models,
each ability estimate has an associated standard error of
measurement (SEM). The estimates of the SEM are dis-
played in Fig. 4. The general shape of the three curves
shows that the SEM is not constant across the range of
tests. The standard error of the HRQoLDA, WHOQOL-
BREF and DUQOL measures are smaller in the center of
the HRQoL continuum and bigger on the extremes. The
mean of SEM in the interval [−2.5, −1.6] was 0.42 logits
for the HRQoLDA, 0.34 logits for the WHOQOL-BREF
and 0.60 logits for the DUQOL. The mean of SEM in the
interval [−0.5, 0.4] was 0.19 logits for the HRQoLDA, 0.18
logits for the WHOQOL-BREF and 0.12 logits for the
DUQOL. The mean of SEM in the interval [1.5, 2.4] was
0.42, 0.31 and 0.52 logits for the HRQoLDA, the
WHOQOL-BREF and the DUQOL respectively.
Discussion
The HRQoL is considered one of the essential measures
required for the optimal assessment of the results of
treatment interventions in drug dependence. Consider-
ing that the evaluation of quality of life of substance
users is usually performed with different tests, the ob-
jective of this study was to establish the concordance
among the HRQoLDA, the DUQOL (which is a specific
assessment tool for substance use), and the WHOQOL-
BREF (a widely used generic quality of life measurement
instrument). Although there are comparative studies
with different QoL assessment tools in the context of
several specific disorders [22, 23], to the authors’ know-
ledge, this is the first time that results of a comparative
study with specific HRQoL assessment tools for sub-
stance use is presented. In addition, in this study an IRT
approach was followed to establish the concordance of
generic and specific QoL assessment tools.
The results here presented indicate moderate to high
correlation among all three tests. The results also dem-
onstrated a higher concordance between the HRQoLDA
and WHOQOL-BREF than between the HRQoLDA and
the DUQOL. However, it cannot be established un-
equivocally, on the basis of the above-presented results,
that the scores of these tools are concordant, given the
low values of RiU indexes. It has been advocated that, if
a variable cannot reduce uncertainty by at least 50 %, it
is unlikely that the predictor can serve as a valid surro-
gate, via concordance, for the score being predicted [15].
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Fig. 3 The HRQOLDA, WHOQOL-BREF and DUQOL item maps
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From a psychometric perspective, the advantages of
IRT models and Rasch models, in particular, are ob-
tained when data fit to model. The results have shown
that data from all three tests fit adequately the RSM.
Therefore, in all three tests, the pattern of responses
produced by participants follow a common conceptual
logic. One of the advantages of the RSM is that, when-
ever data fit the model, measurement levels area trans-
formed from an ordinal to an interval scale. The
construct of HRQoL is usually explored as an outcome
in efficacy and effectiveness analyses. Thus, working with
scores in an interval scale, instead of an ordinal one, is
preferable both for the purpose of improving the inter-
pretation of scores produced by research participants, as
in this particular case, and for conducting the statistical
analysis of data.
On the map of the scale’s items, the location to each
item can be identified on the HRQoL continuum. The
HRQoLDA is a test that evaluates the widest range within
the HRQoL continuum, followed by the WHOQOL-BREF
and by the DUQOL. This distribution of items is import-
ant to avoid floor and ceiling effects observed in previous
studies [9]. It has been noticed that the HRQoLDA is the
most effective test whenever a low or high severity of im-
pairment is predominant in a given sample. Nevertheless,
the HRQoLDA can also perform with sensitivity in pre-
post study designs on any occasion a significant impact of
treatment is expected. Notwithstanding, it has also been
shown that the WHOQOL-BREF is sensitive to detect
measurement changes in pre-post study designs [24].
In terms of accuracy, the DUQOL is the test that has
demonstrated a lower error of measurement (higher ac-
curacy in the central area of the continuum). Contrarily,
the WHOQOL-BREF revealed more accurate scores on
the extreme areas of the continuum, which was slightly
superior and more accurate than the HRQoLDA on the
same area of the continuum. In terms of reliability, all
three tests reveal similar and adequate results. The Per-
son Separation Index (PSI) was similar in both the
WHOQOL-BREF and the HRQoLDA tests, while super-
ior than the PSI observed for the DUQOL. Yet, accord-
ing to the proposed psychometric parameters in this
field, all three tests perform adequately for differentiat-
ing between individuals whose scores are located at dif-
ferent points along the continuum of the HRQoL
construct. The three tests showed adequate values of
Item Separation Index (ISI). The ISI was significantly
higher in the HRQoLDA, which indicates that the
HRQoLDA items perform at a superior level along the
HRQoL continuum.
In summary, the DUQoL is the most accurate instru-
ment for the central area of the distribution of scores,
but it is also the test with the narrowest range of item
measures. Such characteristic can limit its usefulness in
heterogeneous patient samples (especially if individuals
present with extreme scores). The WHOQOL is the best
instrument for comparing the scores among groups of
patients and for general population use, given its con-
ception and design as a generic instrument. Finally, the
results of this study show that the HRQoLDA may be
the most suitable tool to be utilized in efficiency and
effectiveness studies. The HRQoLDA is the instrument
with a widest range of item measures; it presents with
less probability of floor and ceiling effects. This is par-
ticularly useful in the detection of clinically significant
changes for more extreme scores.
Fig. 4 Estimated errors standard of measurement of HRQOLDA, WHOQOL-BREF and DUQOL instruments along the HRQOL continuum
Rojas et al. Health and Quality of Life Outcomes  (2015) 13:186 Page 10 of 11
One of the limitations of this study relates to the sam-
ple size (121 participants). In spite of this limitation, it
has been demonstrated in simulation studies that Rasch
analyses are able to produce precise estimations (items
and persons parameters) in analysis with samples with
100 or more participants [25].
Conclusions
The results of this study reveal a high correlation be-
tween the scores of the HRQOLDA and WHOQOL-
BREF questionnaire and a moderate correlation between
the scores of the HRQOLDA and DUQOL question-
naire. There was a higher concordance (like a procedure
of transformations between the scores from one test to
another) between the HRQoLDA and WHOQOL-BREF
than between the HRQoLDA and the DUQOL. How-
ever, it cannot be established unequivocally that the
scores of these tools are concordant. In this study, the
utility of the application of the Rasch model was demon-
strated in the process of producing an empirical bench-
mark for the selection of measurement tools to be used
in the context of health care and research.
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